Carboximidamides

O-tert-Butyl-N,N'-diisopropylisourea 98.0+%, TCI America™

CAS: 71432-55-8 Molecular Formula: C11H24N2O Molecular Weight (g/mol): 200.326 MDL Number: MFCD06657672 InChI Key: FESDUDPSRMWIDL-UHFFFAOYSA-N Synonym: 2-tert-Butyl-1,3-diisopropylisourea PubChem CID: 11041782 IUPAC Name: tert-butyl N,N'-di(propan-2-yl)carbamimidate SMILES: CC(C)NC(=NC(C)C)OC(C)(C)C

Chem-Impex International, Inc. 2-tert-Butyl-1,3-diisopropylisourea | 71432-55-8 | MFCD06657672 | 1G

2-tert-Butyl-1,3-diisopropylisourea, 71432-55-8, MFCD06657672, 1G

Chem-Impex International, Inc. 2-tert-Butyl-1,3-diisopropylisourea | 71432-55-8 | MFCD06657672 | 5G

2-tert-Butyl-1,3-diisopropylisourea, 71432-55-8, MFCD06657672, 5G

Chem-Impex International, Inc. 2-tert-Butyl-1,3-diisopropylisourea | 71432-55-8 | MFCD06657672 | 25G

2-tert-Butyl-1,3-diisopropylisourea, 71432-55-8, MFCD06657672, 25G

eMolecules​ Ambeed / tert-Butyl NN-diisopropylcarbamimidate / 250mg / 525000482 / A109935 / / 71432-55-8 / MFCD22123489 / 200.326 / C11H24N2O

Ambeed / tert-Butyl NN-diisopropylcarbamimidate / 250mg / 525000482 / A109935 / / 71432-55-8 / MFCD22123489 / 200.326 / C11H24N2O

eMolecules​ Ambeed / 55-(14-Phenylene)dipicolinaldehyde / 100mg / 603089926 / A1226399 / / 1399191-70-8 / [null] / 288.306 / C18H12N2O2

Ambeed / 55-(14-Phenylene)dipicolinaldehyde / 100mg / 603089926 / A1226399 / / 1399191-70-8 / [null] / 288.306 / C18H12N2O2

Apexbio Technology LLC MRTX-1133(Synonyms: MRTX1133, MRTX 1133, Mirati-1133, KRAS G12D inhibitor MRTX1133), 1mg, CAS: 2621928-55-8.

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

MRTX-1133 (CAS 2621928-55-8) is a non-covalent alkyne-based inhibitor specifically targeting the KRAS G12D mutant protein It binds KRAS G12D with sub-picomolar affinity occupying the Switch II pocket and forming multiple intermolecular interactions Through these interactions MRTX-1133 disrupts SOS1-mediated guanine nucleotide exchange and prevents the assembly of KRAS-GTP/RAF1 signaling complexes thereby inhibiting downstream KRAS-driven signaling pathways MRTX-1133 is applied in cancer biology research to investigate tumor signaling and therapeutic strategies involving KRAS G12D mutations

Apexbio Technology LLC MRTX-1133(Synonyms: MRTX1133, MRTX 1133, Mirati-1133, KRAS G12D inhibitor MRTX1133), 10mg, CAS: 2621928-55-8.

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

MRTX-1133 (CAS 2621928-55-8) is a non-covalent alkyne-based inhibitor specifically targeting the KRAS G12D mutant protein It binds KRAS G12D with sub-picomolar affinity occupying the Switch II pocket and forming multiple intermolecular interactions Through these interactions MRTX-1133 disrupts SOS1-mediated guanine nucleotide exchange and prevents the assembly of KRAS-GTP/RAF1 signaling complexes thereby inhibiting downstream KRAS-driven signaling pathways MRTX-1133 is applied in cancer biology research to investigate tumor signaling and therapeutic strategies involving KRAS G12D mutations

Apexbio Technology LLC MRTX-1133(Synonyms: MRTX1133, MRTX 1133, Mirati-1133, KRAS G12D inhibitor MRTX1133), 5mg, CAS: 2621928-55-8.

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

MRTX-1133 (CAS 2621928-55-8) is a non-covalent alkyne-based inhibitor specifically targeting the KRAS G12D mutant protein It binds KRAS G12D with sub-picomolar affinity occupying the Switch II pocket and forming multiple intermolecular interactions Through these interactions MRTX-1133 disrupts SOS1-mediated guanine nucleotide exchange and prevents the assembly of KRAS-GTP/RAF1 signaling complexes thereby inhibiting downstream KRAS-driven signaling pathways MRTX-1133 is applied in cancer biology research to investigate tumor signaling and therapeutic strategies involving KRAS G12D mutations